dr. elhassadi on the relationship between p53 expression and prognosis in mcl
Published 5 years ago • 59 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:56
dr. elhassadi discusses the outlook of patients with p53-mutated mcl
-
1:23
dr. elhassadi on 10-year single-center experience with tp53 status in mcl
-
2:12
dr. elhassadi on the subtypes of mcl
-
2:13
dr. rule on patients with p53-mutated mcl
-
1:49
dr. shah on treatment of patients with p53-mutated mcl
-
1:03
dr. eskelund on outcomes of tp53-mutated mcl
-
5:50
multiple findings including gall stones, single kidney, and hepatic mass.
-
2:02:44
update 2022 of the classification of mature b cell lymphomas
-
47:23
lymphoplasmacytic neoplasms: cases and differentials
-
1:15
dr. rule on treatment approaches for patients with p53-mutated mcl
-
1:36
fibronectin and mutant p53 gene make for deadly duo in ovarian carcinomas
-
4:08
mantle cell lymphoma: impact of genetic variants
-
1:46:56
cshl keynote: dr. david lane, a*star , p53 laboratory
-
1:45
dr. o'connor on recent fda approvals in mcl
-
10:48
dermatofibroma with hemosiderin laden touton giant cells (pathology dermpath dermatology)
-
6:00
mantle cell lymphoma: improved prognosis
-
3:07
understanding the heterogeneity of mantle cell lymphoma
-
1:31
dr. eskelund on study of tp53 mutations in mantle cell lymphoma
-
1:17
dr. lacasce on key advances in the mcl paradigm
-
5:35
autoimmune and infectious diseases among diffuse large b-cell lymphoma survivors
-
3:57
stanford cancer genetics program: nicole’s story
-
10:12
novel genetic analysis of mrl mice reveals that complement inhibition by factor h reduces scarring